Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims

In yet another opioid settlement, Teva has agreed to pay $24.8 million over 13 years, plus provide $20 million worth of Narcan over 10 years, to resolve its share of the litigation in San Francisco. Meanwhile, AbbVie's Allergan unit will pay $13 million to escape the claims.